Chong Kun Dang Pharmaceutical (XKRX:185750) Operating Cash Flow per Share : ₩25,292.54 (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Operating Cash Flow per Share?

Chong Kun Dang Pharmaceutical's operating cash flow per share for the three months ended in Mar. 2024 was ₩3,582.96. Chong Kun Dang Pharmaceutical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩25,292.54.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Chong Kun Dang Pharmaceutical was 226.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 46.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share or its related term are showing as below:

XKRX:185750' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -32.7 Med: 10.45 Max: 80.7
Current: 46.6

During the past 11 years, Chong Kun Dang Pharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 80.70% per year. The lowest was -32.70% per year. And the median was 10.45% per year.

XKRX:185750's 3-Year OCF Growth Rate is ranked better than
86.62% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.4 vs XKRX:185750: 46.60

Chong Kun Dang Pharmaceutical Operating Cash Flow per Share Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Operating Cash Flow per Share Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

5,874.49

7,934.57

988.80

5,031.53

25,006.67

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															3,178.41	3,893.09	6,644.94	11,171.56	3,582.96

Competitive Comparison of Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Chong Kun Dang Pharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chong Kun Dang Pharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chong Kun Dang Pharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chong Kun Dang Pharmaceutical's Price-to-Operating-Cash-Flow falls into.

Chong Kun Dang Pharmaceutical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	318159.906	/	12.723
	=	25,006.67

Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	45517.925	/	12.704
	=	3,582.96

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩25,292.54

Chong Kun Dang Pharmaceutical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines